Stuart B. Rosenblum

1.2k citations

23 papers · 725 indexed · h-index 13

Co-authors: Adriano Afonso Tram Huynh Harry R. Davis John W. Clader Nathan Yumibe Duane A. Burnett Joseph A. Kozlowski Ron Bihovsky
Topics: Chemokine receptors and signaling (7 papers)Immunotherapy and Immune Responses (6 papers)Synthesis of β-Lactam Compounds (4 papers)
Cited by: Organic Chemistry Immunology Oncology
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry The Journal of Organic Chemistry
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Stuart B. Rosenblum

22 papers receiving 690 citations

Peers

Countries citing papers authored by Stuart B. Rosenblum

Since Specialization

Citations

This map shows the geographic impact of Stuart B. Rosenblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart B. Rosenblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart B. Rosenblum more than expected).

Fields of papers citing papers by Stuart B. Rosenblum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart B. Rosenblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart B. Rosenblum. The network helps show where Stuart B. Rosenblum may publish in the future.

Co-authorship network of co-authors of Stuart B. Rosenblum

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart B. Rosenblum. A scholar is included among the top collaborators of Stuart B. Rosenblum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart B. Rosenblum. Stuart B. Rosenblum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Prescription Data for Intrathecal Drug Delivery: A Retrospective Analysis in 32,784 Patients 2024 ·Neuromodulation Technology at the Neural Interface ·(unknown),(unknown),(unknown),Stuart B. Rosenblum,(unknown),Sanjeet Narang	0
2	IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: Improved PK, hERG and metabolic profiles 2014 ·Bioorganic & Medicinal Chemistry Letters ·Anilkumar G. Nair,Michael Wong,Youheng Shu,Yueheng Jiang,Chung‐Her Jenh,Seong Heon Kim,Deyi Yang,Qingbei Zeng,(unknown),(unknown),(unknown),Brian McGuinness,(unknown),Doug W. Hobbs,Neng‐Yang Shih,Stuart B. Rosenblum,Joseph A. Kozlowski	12
3	Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·Qingbei Zeng,Stuart B. Rosenblum,Zhaoxia Yang,Yueheng Jiang,Kevin D. McCormick,Robert Aslanian,(unknown),Joseph A. Kozlowski,Neng‐Yang Shih,John A. Hey,Robert E. West,Walter A. Korfmacher,Michael Berlin,Christopher W. Boyce	5
4	A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection 2012 ·BMC Immunology ·Chung‐Her Jenh,Mary Ann Cox,Long Cui,Eva‐Pia Reich,Lisa Sullivan,Shu‐Cheng Chen,David Kinsley,Shiguang Qian,Seong Heon Kim,Stuart B. Rosenblum,Joseph A. Kozlowski,Jay S. Fine,Paul J. Zavodny,Daniel Lundell	74
5	Synthesis of New 4,5-Dihydrofuranoindoles and Their Evaluation as HCV NS5B Polymerase Inhibitors 2012 ·Organic Letters ·Francisco Velázquez,Srikanth Venkatraman,Charles A. Lesburg,José S. Duca,Stuart B. Rosenblum,Joseph A. Kozlowski,F. George Njoroge	24
6	A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection 2012 ·BMC Immunology ·(unknown),Mary Ann Cox,Long Cui,Eva‐Pia Reich,Lisa Sullivan,Shu‐Cheng Chen,David Kinsley,Shiguang Qian,Seong Heon Kim,Stuart B. Rosenblum,Joseph A. Kozlowski,Jay S. Fine,Paul J. Zavodny,Daniel Lundell	73
7	Targeting CXCR3 reduces ligand-induced T-Cell activation but not development of lung allergic responses 2011 ·Annals of Allergy Asthma & Immunology ·Yoo Seob Shin,Katsuyuki Takeda,Hiroshi Ohnishi,Yi Jia,Yoshiki Shiraishi,(unknown),Jay S. Fine,Stuart B. Rosenblum,(unknown),Chung‐Her Jenh,Denise Manfra,Erwin W. Gelfand	2
8	III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold 2011 ·Bioorganic & Medicinal Chemistry Letters ·Seong Heon Kim,G. Anilkumar,(unknown),Qingbei Zeng,Deyi Yang,(unknown),(unknown),(unknown),Wensheng Yu,Yueheng Jiang,Chung‐Her Jenh,James W. Hall,(unknown),Doug W. Hobbs,John J. Baldwin,Brian McGuinness,Stuart B. Rosenblum,Joseph A. Kozlowski,Bandarpalle B. Shankar,Neng‐Yang Shih	15
9	II. SAR studies of pyridyl–piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),G. Anilkumar,(unknown),(unknown),James W. Hall,Doug W. Hobbs,Yueheng Jiang,Chung‐Her Jenh,Seong Heon Kim,Joseph A. Kozlowski,Brian McGuinness,Stuart B. Rosenblum,(unknown),Neng‐Yang Shih,Youheng Shu,Michael Wong,Wensheng Yu,(unknown),Qingbei Zeng	16
10	Novel CXCR3 antagonists with a piperazinyl-piperidine core 2009 ·Bioorganic & Medicinal Chemistry Letters ·Brian McGuinness,(unknown),(unknown),(unknown),(unknown),Doug W. Hobbs,(unknown),James W. Hall,Chung‐Her Jenh,Joseph A. Kozlowski,G. Anilkumar,Stuart B. Rosenblum	21
11	CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis 2009 ·Journal of Inflammation ·Yuanfan Wang,Long Cui,Waldemar Gonsiorek,Soo Min,G. Anilkumar,Stuart B. Rosenblum,Joseph A. Kozlowski,Daniel Lundell,Jay S. Fine,Ethan Grant	46
12	Identification of a novel, orally bioavailable histamine H3 receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template 2002 ·Bioorganic & Medicinal Chemistry Letters ·Robert Aslanian,(unknown),(unknown),Kevin D. McCormick,John J. Piwinski,Pauline C. Ting,(unknown),Michael Berlin,Xiaohong Zhu,(unknown),Stuart B. Rosenblum,Yueheng Jiang,Robert West,(unknown),Shirley M. Williams,Matthew Bryant,John A. Hey	24
13	Analogues of 1-(3,10-Dibromo-8-chloro-6,11-dihydro-5 H -benzo[5,6]-cyclohepta[1,2- b ]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase 1999 ·Bioorganic & Medicinal Chemistry ·Adriano Afonso,Jay Weinstein,Joseph Kelly,Ronald Wolin,Stuart B. Rosenblum,(unknown),Timothy J. Guzi,Linda James,Donna Carr,Robert Patton,W. Robert Bishop,(unknown),(unknown),Larry Heimark,(unknown),Amin A. Nomeir	8
14	Inhibitors of farnesyl protein transferase. synthesis and biological activity of amide and cyanoguanidine derivatives containing a 5,11-dihydro[1]benzthiepin, benzoxepin, and benzazepin [4,3-b]pyridine ring system 1998 ·Bioorganic & Medicinal Chemistry Letters ·Ronald Wolin,(unknown),Joseph Kelly,Jay Weinstein,Stuart B. Rosenblum,Adriano Afonso,Linda James,Paul T. Kirschmeier,W. Robert Bishop	12
15	Beta-lactams derived from the reaction of phenanthridines and 11H-dibenzo[b,e]azepin-11-one with phenylvaleryl chloride. Synthesis of fused analogs of the cholesterol absorption inhibitor Sch 48461 1998 ·Tetrahedron Letters ·Adriano Afonso,Stuart B. Rosenblum,Mohindar S. Puar,Andrew T. McPhail	14
16	ChemInform Abstract: Beta‐Lactams Derived from the Reaction of Phenanthridines and 11H‐Dibenzo[b,e]azepin‐11‐one with Phenylvaleryl Chloride. Synthesis of Fused Analogues of the Cholesterol Absorption Inhibitor Sch 48461. 1998 ·ChemInform ·Adriano Afonso,Stuart B. Rosenblum,(unknown),Andrew T. McPhail	1
17	Discovery of 1-(4-Fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)- hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption 1998 ·Journal of Medicinal Chemistry ·Stuart B. Rosenblum,Tram Huynh,Adriano Afonso,Harry R. Davis,Nathan Yumibe,John W. Clader,Duane A. Burnett	280
18	Neutralizing monoclonal antibodies against α and β subunits of theUstilago maydis virus encoded toxin 1992 ·Virus Genes ·Idit Ginzberg,Stuart B. Rosenblum,Y. Koltin,Nechama I. Smorodinsky	1
19	Nucleophilic displacements on an .alpha.-chloro thioether by organocuprates: a novel synthesis of desoxybiotin 1986 ·The Journal of Organic Chemistry ·Hans Aaron Bates,Stuart B. Rosenblum	12
20	300 Mhz 1H NMR spectra and conformations of biotin and related hexahydrothienoimidazolone derivatives 1985 ·Tetrahedron ·Hans Aaron Bates,Stuart B. Rosenblum	10

About Stuart B. Rosenblum

Stuart B. Rosenblum is a scholar working on Immunology, Oncology and Toxicology, having authored 23 papers that have together received 725 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (7 papers), Immunotherapy and Immune Responses (6 papers) and Synthesis of β-Lactam Compounds (4 papers). The work is most often cited by research in Organic Chemistry (326 citations), Immunology (179 citations) and Oncology (204 citations). Stuart B. Rosenblum has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Adriano Afonso, Tram Huynh, Harry R. Davis, John W. Clader, Nathan Yumibe, Duane A. Burnett, Joseph A. Kozlowski, Ron Bihovsky, Jay S. Fine and Long Cui. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact